Melinta Therapeutics Current Ratio 2010-2019 | MLNT

Melinta Therapeutics current ratio from 2010 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Melinta Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-03-31 $0.18B $0.13B 1.40
2018-12-31 $0.15B $0.13B 1.12
2018-09-30 $0.17B $0.12B 1.34
2018-06-30 $0.21B $0.11B 1.97
2018-03-31 $0.15B $0.10B 1.48
2017-12-31 $0.15B $0.03B 4.72
2017-09-30 $0.18B $0.02B 11.48
2017-06-30 $0.19B $0.02B 12.04
2017-03-31 $0.21B $0.02B 8.88
2016-12-31 $0.02B $0.02B 0.64
2016-09-30 $0.25B $0.03B 10.18
2016-06-30 $0.26B $0.03B 10.39
2016-03-31 $0.23B $0.02B 11.82
2015-12-31 $0.16B $0.02B 9.05
2015-09-30 $0.19B $0.02B 8.83
2015-06-30 $0.21B $0.02B 9.54
2015-03-31 $0.23B $0.02B 13.32
2014-12-31 $0.11B $0.02B 5.80
2014-09-30 $0.08B $0.02B 5.36
2014-06-30 $0.07B $0.01B 6.55
2014-03-31 $0.08B $0.01B 7.99
2013-12-31 $0.10B $0.01B 9.07
2013-09-30 $0.11B $0.01B 16.06
2013-06-30 $0.12B $0.00B 30.34
2013-03-31 $0.06B $0.01B 10.43
2012-12-31 $0.07B $0.01B 13.17
2012-09-30 $0.05B $0.00B 14.68
2012-06-30 $0.06B $0.01B 12.26
2012-03-31 $0.07B $0.00B 18.79
2011-12-31 $0.02B $0.01B 3.31
2011-09-30 $0.00B 0.00
2011-06-30 $0.00B 0.00
2011-03-31 $0.00B 0.00
2010-12-31 $0.02B $0.00B 10.22
2009-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.044B $0.096B
Melinta Therapeutics, Inc. develops and commercializes novel antibiotics designed to provide new and better therapeutic solutions. Melinta's lead product is Baxdela, an antibiotic approved by the US FDA for use in the treatment of acute bacterial skin and skin structure infections (ABSSSI). Melinta also has an extensive pipeline of preclinical and clinical stage products that were developed internally or assumed under the 2017 acquisition of Cempra, Inc. This pipeline includes many important classes of antibiotics, each targeted at a different segment of the anti-infective market. Melinta is headquartered in New Haven, CT.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.414B 34.76
Astellas Pharma (ALPMY) Japan $28.829B 14.14
Takeda Pharmaceutical (TAK) Japan $27.169B 7.98
UCB SA (UCBJF) Belgium $15.866B 0.00
Eisai (ESALY) Japan $15.853B 27.26
Grifols, S.A (GRFS) Spain $15.092B 19.09
Merck (MKGAF) Germany $13.293B 18.14
IPSEN SA ADR (IPSEY) France $10.783B 0.00
Ionis Pharmaceuticals (IONS) United States $9.459B 20.68
Sage Therapeutics (SAGE) United States $9.292B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.044B 0.00
Catalent (CTLT) United States $7.834B 31.44
Jazz Pharmaceuticals (JAZZ) Ireland $7.794B 10.69
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
STADA ARZNEIMI (STDAF) Germany $5.634B 0.00
Nektar Therapeutics (NKTR) United States $5.574B 9.09
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.420B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.818B 16.93
Tilray (TLRY) Canada $4.302B 0.00
Evotec AG (EVTCY) Germany $4.265B 45.78
FibroGen (FGEN) United States $3.980B 0.00
United Therapeutics (UTHR) United States $3.335B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.191B 11.45
Arrowhead Pharmaceuticals (ARWR) United States $2.704B 407.43
PTC Therapeutics (PTCT) United States $2.503B 0.00
Xencor (XNCR) United States $2.493B 68.05
Zogenix (ZGNX) United States $2.019B 0.00
Portola Pharmaceuticals (PTLA) United States $1.763B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.672B 80.96
Ironwood Pharmaceuticals (IRWD) United States $1.639B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.607B 21.97
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Heron Therapeutics (HRTX) United States $1.516B 0.00
USANA Health Sciences (USNA) United States $1.412B 12.27
Corcept Therapeutics (CORT) United States $1.226B 17.49
ArQule (ARQL) United States $1.132B 0.00
Aerie Pharmaceuticals (AERI) United States $1.103B 0.00
Radius Health (RDUS) United States $1.038B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.016B 3.66
Theravance Biopharma (TBPH) Cayman Islands $0.994B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.882B 0.00
Endo (ENDP) Ireland $0.792B 1.27
Concordia (CXRXF) Canada $0.719B 0.00
Aptorum Group (APM) China $0.678B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.602B 0.00
Organogenesis Holdings (ORGO) United States $0.584B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.582B 0.00
TherapeuticsMD (TXMD) United States $0.567B 0.00
GlycoMimetics (GLYC) United States $0.535B 0.00
Translate Bio (TBIO) United States $0.495B 0.00
Karyopharm Therapeutics (KPTI) United States $0.480B 0.00
ChemoCentryx (CCXI) United States $0.471B 0.00
Akebia Therapeutics (AKBA) United States $0.462B 0.00
Dermira (DERM) United States $0.460B 0.00
Siga Technologies (SIGA) United States $0.460B 1.08
BioSpecifics Technologies Corp (BSTC) United States $0.455B 22.94
Dova Pharmaceuticals (DOVA) United States $0.452B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.434B 0.00
CV Sciences (CVSI) United States $0.421B 0.00
Flexion Therapeutics (FLXN) United States $0.418B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.416B 0.00
Indivior (INVVY) United States $0.415B 1.50
Corbus Pharmaceuticals Holdings (CRBP) United States $0.408B 0.00
CannTrust Holdings (CTST) Canada $0.404B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.396B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.382B 0.00
Innate Pharma SA (IPHYF) France $0.369B 0.00
Collegium Pharmaceutical (COLL) United States $0.362B 0.00
Harpoon Therapeutics (HARP) United States $0.346B 0.00
ImmunoGen (IMGN) United States $0.339B 0.00
Xeris Pharmaceuticals (XERS) United States $0.321B 0.00
KalVista Pharmaceuticals (KALV) United States $0.302B 0.00
Rafael Holdings (RFL) United States $0.294B 0.00
OptiNose (OPTN) United States $0.293B 0.00
Molecular Templates (MTEM) United States $0.276B 0.00
Concert Pharmaceuticals (CNCE) United States $0.267B 0.00
Aratana Therapeutics (PETX) United States $0.241B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.238B 0.00
Recro Pharma (REPH) United States $0.224B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.223B 0.00
Lannett Co Inc (LCI) United States $0.219B 2.13
Ocular Therapeutix (OCUL) United States $0.206B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.197B 0.00
Redhill Biopharma (RDHL) Israel $0.181B 0.00
Calithera Biosciences (CALA) United States $0.169B 0.00
Nature's Sunshine Products (NATR) United States $0.169B 54.69
Taiwan Liposome (TLC) Taiwan $0.166B 0.00
Ardelyx (ARDX) United States $0.163B 0.00
IMV INC (IMV) Canada $0.161B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.148B 0.00
MEI Pharma (MEIP) United States $0.143B 0.00
Jounce Therapeutics (JNCE) United States $0.140B 0.00
Majesco Entertainment (PTE) United States $0.134B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.133B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.126B 0.00
DURECT (DRRX) United States $0.113B 0.00
AgeX Therapeutics (AGE) United States $0.110B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.104B 0.00
Generex Biotechnology (GNBT) United States $0.104B 0.00
Aquestive Therapeutics (AQST) United States $0.103B 0.00
RENEURON GP (RNUGF) United Kingdom $0.094B 0.00
Infinity Pharmaceuticals (INFI) United States $0.093B 0.00
Capnia (SLNO) United States $0.092B 0.00
Champions Oncology (CSBR) United States $0.091B 0.00
Iterum Therapeutics (ITRM) Ireland $0.091B 0.00
Mast Therapeutics (SVRA) United States $0.090B 0.00
Genocea Biosciences (GNCA) United States $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 62.56
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
MediWound (MDWD) Israel $0.087B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.084B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.084B 0.00
Natural Alternatives (NAII) United States $0.081B 8.07
Cardiome Pharma (CORV) Canada $0.080B 0.00
China SXT Pharmaceuticals (SXTC) China $0.079B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.077B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Nivalis Therapeutics (ALPN) United States $0.075B 0.00
Novan (NOVN) United States $0.072B 0.00
Neos Therapeutics (NEOS) United States $0.071B 0.00
Pharmaxis (PXSLY) Australia $0.067B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.059B 0.00
India Globalization Capital (IGC) United States $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.055B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 0.00